Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

1.

Subepithelial growth patterns in urothelial carcinoma-frequency and prognostic significance.

Gofrit ON, Shapiro A, Pode D, Katz R, Yutkin V, Zorn KC, Pizov G.

Urol Oncol. 2012 Jan-Feb;30(1):49-54. doi: 10.1016/j.urolonc.2009.11.010. Epub 2010 Mar 6.

PMID:
20207557
[PubMed - indexed for MEDLINE]
2.

Clinical significance of subepithelial growth patterns in non-muscle invasive bladder cancer.

Miyake M, Hirao S, Mibu H, Tanaka M, Takashima K, Shimada K, Hirao K.

BMC Urol. 2011 Aug 5;11:17. doi: 10.1186/1471-2490-11-17.

PMID:
21816111
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Prognostic significance in substaging ofT1 urinary bladder urothelial carcinoma on transurethral resection.

Chang WC, Chang YH, Pan CC.

Am J Surg Pathol. 2012 Mar;36(3):454-61. doi: 10.1097/PAS.0b013e31823dafd3.

PMID:
22261706
[PubMed - indexed for MEDLINE]
4.

Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study.

Yang TB, Zeng FH, Sun ZQ.

Chin Med J (Engl). 2006 Nov 5;119(21):1821-8.

PMID:
17097038
[PubMed - indexed for MEDLINE]
Free Article
5.

Reproducibility and prognostic variability of grade and lamina propria invasion in stages Ta, T1 urothelial carcinoma of the bladder.

Bol MG, Baak JP, Buhr-Wildhagen S, Kruse AJ, Kjellevold KH, Janssen EA, Mestad O, Øgreid P.

J Urol. 2003 Apr;169(4):1291-4.

PMID:
12629345
[PubMed - indexed for MEDLINE]
6.

Prognostic role of the tumor-associated tissue inflammatory reaction in transitional bladder cell carcinoma.

Cai T, Nesi G, Boddi V, Mazzoli S, Dal Canto M, Bartoletti R.

Oncol Rep. 2006 Aug;16(2):329-34.

PMID:
16820911
[PubMed - indexed for MEDLINE]
7.

Prognostic factors for upper urinary tract urothelial carcinomas: stage, grade, and smoking status.

Simsir A, Sarsik B, Cureklibatir I, Sen S, Gunaydin G, Cal C.

Int Urol Nephrol. 2011 Dec;43(4):1039-45. doi: 10.1007/s11255-011-9915-z. Epub 2011 Mar 10.

PMID:
21547471
[PubMed - indexed for MEDLINE]
8.

Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy.

Shariat SF, Bolenz C, Godoy G, Fradet Y, Ashfaq R, Karakiewicz PI, Isbarn H, Jeldres C, Rigaud J, Sagalowsky AI, Lotan Y.

J Urol. 2009 Jul;182(1):78-84; discussion 84. doi: 10.1016/j.juro.2009.02.125. Epub 2009 May 17.

PMID:
19447418
[PubMed - indexed for MEDLINE]
9.

Prognostic significance of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in voided urine samples from patients with transitional cell carcinoma of the bladder.

Durkan GC, Nutt JE, Rajjayabun PH, Neal DE, Lunec J, Mellon JK.

Clin Cancer Res. 2001 Nov;7(11):3450-6.

PMID:
11705862
[PubMed - indexed for MEDLINE]
Free Article
10.

Initial high-grade T1 urothelial cell carcinoma: feasibility and prognostic significance of lamina propria invasion microstaging (T1a/b/c) in BCG-treated and BCG-non-treated patients.

Orsola A, Trias I, Raventós CX, Español I, Cecchini L, Búcar S, Salinas D, Orsola I.

Eur Urol. 2005 Aug;48(2):231-8; discussion 238.

PMID:
15963635
[PubMed - indexed for MEDLINE]
11.

Deoxyribonucleic acid content and survival rates of patients with transitional cell carcinoma of the bladder.

al-Abadi H, Nagel R.

J Urol. 1994 Jan;151(1):37-42.

PMID:
8254829
[PubMed - indexed for MEDLINE]
12.

Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.

Stavropoulos NE, Filiadis I, Ioachim E, Hastazeris K, Tsimaris I, Kalogeras D, Stefanaki S, Agnantis NJ.

Anticancer Res. 2002 Nov-Dec;22(6B):3759-64.

PMID:
12552989
[PubMed - indexed for MEDLINE]
13.

S-phase fraction in superficial urothelial carcinoma of the bladder--a prospective, long-term, follow-up study.

Falkman K, Tribukait B, Nyman CR, Larsson P, Norming U.

Scand J Urol Nephrol. 2004;38(4):278-84.

PMID:
15669586
[PubMed - indexed for MEDLINE]
14.

Multivariate analysis of the prognostic factors of primary superficial bladder cancer.

Millán-Rodríguez F, Chéchile-Toniolo G, Salvador-Bayarri J, Palou J, Vicente-Rodríguez J.

J Urol. 2000 Jan;163(1):73-8. Review.

PMID:
10604317
[PubMed - indexed for MEDLINE]
15.

Management of transitional cell carcinoma involving von Brunn's nests.

Dinney CP, Ramirez EI, Swanson DA, Ro JY, Babaian RJ, von Eschenbach AC.

J Urol. 1995 Mar;153(3 Pt 2):944-9.

PMID:
7853580
[PubMed - indexed for MEDLINE]
16.

T1G3 high-risk NMIBC (non-muscle invasive bladder cancer): conservative treatment versus immediate cystectomy.

De Berardinis E, Busetto GM, Antonini G, Giovannone R, Gentile V.

Int Urol Nephrol. 2011 Dec;43(4):1047-57. doi: 10.1007/s11255-011-9941-x. Epub 2011 Mar 29.

PMID:
21442469
[PubMed - indexed for MEDLINE]
17.

Initial tumor stage and grade as a predictive factor for recurrence in patients with stage T1 grade 3 bladder cancer.

Kwak C, Ku JH, Park JY, Lee E, Lee SE, Lee C.

J Urol. 2004 Jan;171(1):149-52. Review.

PMID:
14665864
[PubMed - indexed for MEDLINE]
18.

Recurrence at three months and high-grade recurrence as prognostic factor of progression in multivariate analysis of T1G2 bladder tumors.

Palou J, Rodríguez-Rubio F, Millán F, Algaba F, Rodríguez-Faba O, Huguet J, Villavicencio H.

Urology. 2009 Jun;73(6):1313-7. doi: 10.1016/j.urology.2008.12.047. Epub 2009 Apr 10.

PMID:
19362341
[PubMed - indexed for MEDLINE]
19.

Prognostic factors in survival of patients with stage Ta and T1 bladder urothelial tumors: the role of G1-S modulators (p53, p21Waf1, p27Kip1, cyclin D1, and cyclin D3), proliferation index, and clinicopathologic parameters.

Lopez-Beltran A, Luque RJ, Alvarez-Kindelan J, Quintero A, Merlo F, Requena MJ, Montironi R.

Am J Clin Pathol. 2004 Sep;122(3):444-52.

PMID:
15362377
[PubMed - indexed for MEDLINE]
Free Article
20.

Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.

Kikuchi E, Fujimoto H, Mizutani Y, Okajima E, Koga H, Hinotsu S, Shinohara N, Oya M, Miki T; Cancer Registration Committee of the Japanese Urological Association.

Int J Urol. 2009 Mar;16(3):279-86. doi: 10.1111/j.1442-2042.2008.02235.x. Epub 2009 Jan 20.

PMID:
19207609
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk